Grifols-backed Cardio3 Biosciences that last month raised €19m in its series C round said it is planning a flotation in Brussels, Belgium, and Paris, France.
Investment bank Kempen is sole global coordinator for the initial public offering (IPO) after Cardio3 tried unsuccessfully to float in 2011.